January 25, 2018 [Employee name] [Employee address] Dear [Employee]:OncoMed Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations
Company FiledMarch 9th, 2018 IndustryThis letter (the “Retention Bonus Agreement”) provides terms regarding your eligibility for retention bonus compensation from OncoMed Pharmaceuticals, Inc. (“OncoMed”).
ONCOMED LETTERHEADLetter Agreement • March 9th, 2018 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2018 Company Industry JurisdictionThis letter agreement (this “Agreement”) confirms our recent discussions about your employment as Chairman, President and CEO of OncoMed Pharmaceuticals, Inc. (the “Company”).